Related references
Note: Only part of the references are listed.Current multidisciplinary management of brain metastases
Michael J. Moravan et al.
CANCER (2020)
Health-related quality of life in adult patients with brain metastases after stereotactic radiosurgery: a systematic, narrative review
Eline Verhaak et al.
SUPPORTIVE CARE IN CANCER (2020)
Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Fausto Petrelli et al.
CANCERS (2020)
Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.
Lova Sun et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
IMpower150: Exploratory analysis of brain metastases development.
Federico Cappuzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non -randomised, open -label, phase 2 trial
Sarah B. Goldberg et al.
LANCET ONCOLOGY (2020)
Systemic Anti-PD-1 Immunotherapy Results in PD-1 Blockade on T Cells in the Cerebrospinal Fluid
Jana Portnow et al.
JAMA ONCOLOGY (2020)
Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data
Eric J. Lehrer et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
Lizza E. L. Hendriks et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Atezolizumab in patients with advanced non -small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Shirish M. Gadgeel et al.
LUNG CANCER (2019)
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
Lucio Crino et al.
LUNG CANCER (2019)
Efficacy and safety of immune checkpoint inhibitors in a Danish real life non-small cell lung cancer population: a retrospective cohort study
Birgitte Bjornhart et al.
ACTA ONCOLOGICA (2019)
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases
Diego Cortinovis et al.
ANTICANCER RESEARCH (2019)
1482OOutcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042
A S Mansfield et al.
ANNALS OF ONCOLOGY (2019)
1483PDPembrolizumab (pembro) plus platinum-based chemotherapy (chemo) in NSCLC with brain metastases: Pooled analysis of KEYNOTE-021, 189, and 407
S F Powell et al.
ANNALS OF ONCOLOGY (2019)
Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis
Fausto Petrelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Complications associated with immunotherapy for brain metastases
Thuy T. Tran et al.
CURRENT OPINION IN NEUROLOGY (2019)
Non-small cell lung cancer brain metastases and the immune system: From brain metastases development to treatment
Elie El Rassy et al.
CANCER TREATMENT REVIEWS (2018)
Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients
J. Garde-Noguera et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer
Harper G. Hubbeling et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Intracerebral efficacy and tolerance of nivolumab in non small-cell lung cancer patients with brain metastases
Clement Gauvain et al.
LUNG CANCER (2018)
Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab
Coraline Dumenil et al.
PLOS ONE (2018)
Hyperprogressive disease in patients with non-small cell lung cancer on immunotherapy
Jonathan S. Kurman et al.
JOURNAL OF THORACIC DISEASE (2018)
A tertiary care cancer center experience with carboplatin and pemetrexed in combination with pembrolizumab in comparison with carboplatin and pemetrexed alone in non-squamous non-small cell lung cancer
Muhammad Zubair Afzal et al.
JOURNAL OF THORACIC DISEASE (2018)
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C. Arbour et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Should chemotherapy plus immune checkpoint inhibition be the standard front-line therapy for patients with metastatic non-small cell lung cancer?
Sarah B. Goldberg et al.
CANCER (2018)
Lung brain metastasis pseudoprogression after nivolumab and ipilimumab combination treatment
Marcos Melian et al.
THORACIC CANCER (2018)
Using immunotherapy to boost the abscopal effect
Wilfred Ngwa et al.
NATURE REVIEWS CANCER (2018)
Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas
Sehui Kim et al.
EUROPEAN JOURNAL OF CANCER (2017)
Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases
Kamran A. Ahmed et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
IFCT-1502 CLINIVO: Real-Life Experience with Nivolumab in 600 Patients (Pts) with Advanced Non-Small Cell Lung Cancer (NSCLC)
O. Molinier et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
Matthew D. Hellmann et al.
LANCET ONCOLOGY (2017)
Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases
Isabella C. Glitza et al.
MELANOMA RESEARCH (2017)
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Daniel N. Cagney et al.
NEURO-ONCOLOGY (2017)
1324PTUMOR-INFILTRATING LYMPHOCYTES (TILS) AND PD-L1 EXPRESSION IN NON- SMALL CELL LUNG CANCER BRAIN METASTASES (BM) AND MATCHED PRIMARY TUMORS (PT)
A.S. Berghoff et al.
ANNALS OF ONCOLOGY (2017)
Safety and efficacy analyses of atezolizumab in advanced non-small cell lung cancer (NSCLC) patients with or without baseline brain metastases
R. V. Lukas et al.
ANNALS OF ONCOLOGY (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
The movers and shapers in immune privilege of the CNS
Britta Engelhardt et al.
NATURE IMMUNOLOGY (2017)
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
Anna S. Berghoff et al.
ONCOIMMUNOLOGY (2016)
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer
Solange Peters et al.
CANCER TREATMENT REVIEWS (2016)
Radionecrosis after stereotactic radiotherapy for brain metastases
E. Le Rhun et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases?
Rovel J. Colaco et al.
JOURNAL OF NEUROSURGERY (2016)
Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
Jonathan W. Goldman et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
Elizabeth Dudnik et al.
LUNG CANCER (2016)
Radionecrosis after stereotactic radiotherapy for brain metastases
E. Le Rhun et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Targeting brain metastases in ALK-rearranged non-small-cell lung cancer
Isabella Zhang et al.
LANCET ONCOLOGY (2015)
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U. Lin et al.
LANCET ONCOLOGY (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Role of Local Radiation Therapy in Cancer Immunotherapy
Sandra Demaria et al.
JAMA ONCOLOGY (2015)
Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
Simon J. Dovedi et al.
CANCER RESEARCH (2014)
The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
Kashif Parvez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas
Dong-Yeop Shin et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Characterization of the inflammatory response to solid cancer metastases in the human brain
Anna Sophie Berghoff et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis
Samuel T. Chao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy
Jeremy D. Ruben et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging
CM McPherson et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Share Paper
